What is Umeclidinium-vilanterol?

Category: Prescription Drugs

Most popular types: Anoro Ellipta

false

This is a combination inhalation product that is used for treatment of chronic obstructive pulmonary disease (COPD).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 3

Commonly reported side effects and conditions associated with Umeclidinium-vilanterol

Side effect Patients
Confusion 1
Dry mouth 1

Dosages

Based on patients currently taking Umeclidinium-vilanterol

Dosage Patients
62.5-25 mcg/puff daily 8

Why patients stopped taking Umeclidinium-vilanterol

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
Expense 1
Personal research 1
Side effects too severe 1
See 1 patient who's stopped taking Umeclidinium-vilanterol

Duration

Currently taking Umeclidinium-vilanterol

Duration Patients
6 months - 1 year 1
1 - 2 years 2
2 - 5 years 5

Stopped taking Umeclidinium-vilanterol

Duration Patients
1 - 6 months 1
Adherence
Adherence Evaluations
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 3
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 1
< $25 1
Not specified 1

What people switch to and from

Patients started taking Umeclidinium-vilanterol after stopping:

Treatment Patients
Fluticasone-Salmeterol (Advair Diskus) 4
Albuterol (Albuterol Inhaler) 2
Tiotropium inhaler (Spiriva HandiHaler) 2
Acetylcysteine (Mucinac) 1
Fluticasone furoate-Vilanterol (Breo Ellipta) 1

Show all 7 treatments patients report switching from

Last updated:
There are no evaluations for Umeclidinium-vilanterol.